Organon joins global push to prevent unintended pregnancies FiercePharma
Roche waves goodbye to another indication for Tecentriq FiercePharma
J&J's ketamine nasal spray outperforms traditional depression treatment OutSourcing-Pharma.com
After rumors, Gland 'not aware' that it's up for sale FiercePharma
Could the Latest Science on Psychedelics Revolutionise the Way We Understand Our Minds? Men's Health
GSK survey reveals lupus treatment gaps FiercePharma
Catalent pauses work on unfinished UK biologics plant as it resolves regulatory woes elsewhere FiercePharma
China-developed antidepressant granted market approval Ukrainian News Agency
Autobahn Therapeutics Announces Initiation of a Phase 1 Clinical Trial of ABX-002 for the Treatment for Major Depressive Disorder Yahoo Finance
Autobahn Therapeutics Announces Initiation of a Phase 1 Clinical Trial of ABX-002 for the Treatment for Major Depressive Disorder Business Wire
